ECR Group Study Days in Rome; Finalising Omnibus I; ECR committed to a pragmatic climate policy; EU pharmaceutical policy

ECR Group Study Days in Rome

The European Conservatives and Reformists (ECR) Group will hold its Study Days in Rome from 9 to 12 December. ECR MEPs from 18 Member States will meet with European and national political leaders, experts from industry and research, representatives of the judiciary, and leading voices from religious institutions. The discussions come at a crucial moment for Europe, with major debates underway on migration, competitiveness, agriculture, energy security and defence. The Executive Vice-President of the European Commission, Raffaele Fitto, is also expected to participate. Study Days serve as an internal platform for strategic debate, enabling the exchange of ideas that help shape the ECR Group’s approach to major policy challenges. By focusing on the key issues that will define Europe’s future, the meetings in Rome will support the development of a coherent, ambitious and forward-looking agenda. Link to the event website here.

When: 9–12 December

Where: Rome, Italy

Journalists wishing to attend are kindly asked to request accreditation in advance.

Contacts:

International media:

Michael Strauss — ECR Group Press & Media Team Leader

michael.strauss@europarl.europa.eu | +32 470 88 23 48

Italian media:

Raffaella Viglione — Head of Italian Press; Italian Delegation of the ECR Group

raffaella.viglione@europarl.europa.eu | +39 339 6254774

Working panels are in camera.

A designated media area will be available on site.

Finalising Omnibus I

On Monday, Parliament and Council negotiators will seek to reach an agreement on a proposal to ease sustainability reporting and due diligence obligations for companies, as part of the “Omnibus I” package. After an initiative by the ECR Group and others, Parliament rejected the original Legal Affairs Committee (JURI) mandate during the October II plenary session. During the mini-plenary of 13 November, Parliament backed compromise amendments jointly tabled by the EPP and ECR, which now form the basis for the ongoing interinstitutional negotiations. Following the vote, ECR MEP Tobiasz Bocheński described the outcome as “a long-overdue step towards restoring Europe’s economic strength”. Parliament’s mandate for the negotiations recognises the need to reverse Europe’s decline in competitiveness. The ECR Group hopes for an agreement that prioritises competitiveness, legal clarity, and space for innovation.

When: Monday @ 19:00

ECR committed to a pragmatic climate policy

On Tuesday, Parliament and Council negotiators will seek an agreement on the Commission’s proposal to amend the EU Climate Law. The Commission has proposed setting an interim, binding EU-wide emissions reduction target of 90% by 2040 — a far-reaching objective with potentially serious consequences for Europe’s industrial and defence capabilities. Despite the ECR Group’s efforts to reject or suspend the Commission’s proposal, Parliament enters the negotiations backing this ambitious target, which risks further weakening Europe’s industrial base at a time of growing geopolitical challenges. Europe’s path to climate neutrality must be based on realism and responsibility, not targets detached from economic and security realities. The ECR Group remains committed to a pragmatic climate policy — one that protects the environment while safeguarding Europe’s economy, competitiveness, and citizens’ livelihoods.

When: Tuesday

EU pharmaceutical policy

On Wednesday, Parliament and Council will seek to conclude negotiations on the overhaul of EU pharmaceutical legislation. The reform aims to boost innovation in Europe’s pharmaceutical sector while improving the security of supply, accessibility, and affordability of medicines for patients across the EU.

The ECR Group supports efforts to strengthen Europe’s resilience in the face of medicine shortages and to create a more innovation-friendly environment. At the same time, the Group stresses the need for a balanced approach that preserves competitiveness, avoids excessive regulatory burdens, and ensures that new rules do not undermine Europe’s ability to attract investment in research and development.

When: Wednesday